There was a significant difference in the cumulative incidence of grade III–IV severe acute GVHD between the patients with the CYP3A5*1 allele and the CYP3A5*3/*3 allele (36 vs. 0 %, P = 0.017). The gene discussed is CYP3A5; the disease is acute graft versus host disease.